| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.006 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.41 | 0.007 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |